{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:18Z","timestamp":1786979778270,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00213-021-06031-2","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:23:45Z","timestamp":1638282225000},"page":"1475-1486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evaluation of the terpenes \u03b2-caryophyllene, \u03b1-terpineol, and \u03b3-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement"],"prefix":"10.1007","volume":"239","author":[{"given":"Joshua A.","family":"Bilbrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma T.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-061X","authenticated-orcid":false,"given":"Jenny L.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"6031_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/jmf.2018.0157","volume":"22","author":"DS Aguilar-Avila","year":"2019","unstructured":"Aguilar-Avila DS, Flores-Soto ME, Tapia-Vazquez C, Pastor-Zarandona OA, Lopez-Roa RI, Viveros-Paredes JM (2019) beta-Caryophyllene, a natural sesquiterpene, attenuates neuropathic pain and depressive-like behavior in experimental diabetic mice. J Med Food 22:460\u2013468","journal-title":"J Med Food"},{"key":"6031_CR2","doi-asserted-by":"crossref","unstructured":"Aly E, Khajah MA, Masocha W (2019) beta-Caryophyllene, a CB2-receptor-selective phytocannabinoid, suppresses mechanical allodynia in a mouse model of antiretroviral-induced neuropathic pain. Molecules 25","DOI":"10.3390\/molecules25010106"},{"key":"6031_CR3","unstructured":"Aripiprazole\/Abilify [package insert] (2014) Princeton: Bristol-Myers Squibb Company"},{"issue":"6","key":"6031_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2045125312457586","volume":"2","author":"Z Atakan","year":"2012","unstructured":"Atakan Z (2012) Cannabis, a complex plant: different compounds and different effects on individuals. Therapeutic Advances Psychopharmacol 2(6):241\u2013254. https:\/\/doi.org\/10.1177\/2045125312457586","journal-title":"Therapeutic Advances Psychopharmacol"},{"key":"6031_CR5","volume-title":"Handbook of essential oils: science, technology, and applications","author":"KHC Baser","year":"2016","unstructured":"Baser KHC, Buchbauer G (2016) Handbook of essential oils: science, technology, and applications, 2nd edn. CRC Press, Boca Raton","edition":"2"},{"key":"6031_CR6","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1182\/blood.V92.10.3605","volume":"92","author":"P Carayon","year":"1998","unstructured":"Carayon P, Marchand J, Dussossoy D, Derocq JM, Jbilo O, Bord A, Bouaboula M, Galiegue S, Mondiere P, Penarier G, Fur GL, Defrance T, Casellas P (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92:3605\u20133615","journal-title":"Blood"},{"key":"6031_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","volume":"43","author":"A Castane","year":"2002","unstructured":"Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43:857\u2013867","journal-title":"Neuropharmacology"},{"key":"6031_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 53:55\u201363","journal-title":"J Neurosci Meth"},{"issue":"Imi","key":"6031_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.2.Neuropathic","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DLH, Dworkin RH, Raja SN (2017) HHS public access - pain. Nature Rev Disease Primers 3(Imi):1\u201345. https:\/\/doi.org\/10.1038\/nrdp.2017.2.Neuropathic","journal-title":"Nature Rev Disease Primers"},{"issue":"1","key":"6031_CR10","first-page":"201","volume":"260","author":"DR Compton","year":"1992","unstructured":"Compton DR, Johnson MR, Melvin LS, Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Therapeutics 260(1):201\u2013209","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"6031_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1124\/jpet.117.245704","volume":"366","author":"ZA Curry","year":"2018","unstructured":"Curry ZA, Wilkerson JL, Bagdas D, Kyte SL, Patel N, Donvito G, Mustafa MA, Poklis JL, Niphakis MJ, Hsu KL, Cravatt BF, Gewirtz DA, Damaj MI, Lichtman AH (2018) Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy. J Pharmacol Exp Ther 366:169\u2013183","journal-title":"J Pharmacol Exp Ther"},{"key":"6031_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","volume":"77","author":"L Deng","year":"2015","unstructured":"Deng L, Guindon J, Cornett BL, Makriyannis A, Mackie K, Hohmann AG (2015) Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biol Psychiatry 77:475\u2013487","journal-title":"Biol Psychiatry"},{"issue":"2","key":"6031_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1742-7843.2012.00875.x","volume":"111","author":"MGB de Oliveira","year":"2012","unstructured":"de Oliveira MGB, Marques RB, de Santana MF, Santos ABD, Brito FA, Barreto EO, de Sousa DP, Almeida FRC, Badau\u00ea-Passos D, Antoniolli \u00c2R, Quintans-J\u00fanior LJ (2012) \u03b1-Terpineol reduces mechanical hypernociception and inflammatory response. Basic Clin Pharmacol Toxicol 111(2):120\u2013125. https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00875.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"6031_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/npp.2017.204","volume":"43","author":"G Donvito","year":"2018","unstructured":"Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG, Lichtman AH (2018) The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain. Neuropsychopharmacology 43:52\u201379","journal-title":"Neuropsychopharmacology"},{"key":"6031_CR15","unstructured":"Gabapentin\/Neurontin [package insert]. New York: Pfizer Inc; 2017."},{"key":"6031_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Galiegue","year":"1995","unstructured":"Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54\u201361","journal-title":"Eur J Biochem"},{"issue":"26","key":"6031_CR17","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105(26):9099\u20139104. https:\/\/doi.org\/10.1073\/pnas.0803601105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March","key":"6031_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopha.2018.06.027","volume":"105","author":"DN Gouveia","year":"2018","unstructured":"Gouveia DN, Costa JS, Oliveira MA, Rabelo TK, de Silva AMO, Carvalho AA, Miguel-dos-Santos R, Lauton-Santos S, Scotti L, Scotti MT, dos Santos MRV, Quintans-J\u00fanior LJ, de Albuquerque Junior RLC, Guimar\u00e3es AG (2018) \u03b1-Terpineol reduces cancer pain via modulation of oxidative stress and inhibition of iNOS. Biomed Pharmacother 105(March):652\u2013661. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.027","journal-title":"Biomed Pharmacother"},{"key":"6031_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","volume":"153","author":"J Guindon","year":"2008","unstructured":"Guindon J, Hohmann AG (2008) Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153:319\u2013334","journal-title":"Br J Pharmacol"},{"key":"6031_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/13880209.2010.504966","volume":"49","author":"V Hajhashemi","year":"2011","unstructured":"Hajhashemi V, Sajjadi SE, Zomorodkia M (2011) Antinociceptive and anti-inflammatory activities of Bunium persicum essential oil, hydroalcoholic and polyphenolic extracts in animal models. Pharm Biol 49:146\u2013151","journal-title":"Pharm Biol"},{"key":"6031_CR21","unstructured":"Haloperidol\/Haldol [package insert] (2009) Beerse, Belgium: Janssen Pharmaceutica N.V"},{"issue":"12","key":"6031_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/c6np00074f","volume":"33","author":"LO Hanus","year":"2016","unstructured":"Hanus LO, Meyer SM, Munoz E, Taglialatela-Scafati O, Appendino G (2016) Phytocannabinoids: a unified critical inventory. Natural Product Reports 33(12):1357\u20131392. https:\/\/doi.org\/10.1039\/c6np00074f","journal-title":"Natural Product Reports"},{"key":"6031_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","volume-title":"CB1 and CB2 receptor pharmacology. In Advances in Pharmacology","author":"AC Howlett","year":"2017","unstructured":"Howlett AC, Abood ME (2017) CB1 and CB2 receptor pharmacology. In Advances in Pharmacology, vol 80. Academic Press Inc., pp 169\u2013206. https:\/\/doi.org\/10.1016\/bs.apha.2017.03.007"},{"key":"6031_CR24","first-page":"132","volume":"101","author":"S Irwin","year":"1951","unstructured":"Irwin S, Houde RW, Bennett DR, Hendershot LC, Seevers MH (1951) The effects of morphine methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J Pharmacol Exp Ther 101:132\u2013143","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"6031_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/j.1532-2149.2012.00242.x","volume":"17","author":"S Katsuyama","year":"2013","unstructured":"Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, Bagetta G, Sakurada T, Sakurada S (2013) Involvement of peripheral cannabinoid and opioid receptors in b-caryophyllene-induced antinociception. Eur J Pain (United Kingdom) 17(5):664\u2013675. https:\/\/doi.org\/10.1002\/j.1532-2149.2012.00242.x","journal-title":"Eur J Pain (United Kingdom)"},{"key":"6031_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577\u20131579","journal-title":"Br J Pharmacol"},{"key":"6031_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2010.09.004","volume":"60","author":"SG Kinsey","year":"2011","unstructured":"Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH (2011) The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology 60:244\u2013251","journal-title":"Neuropharmacology"},{"issue":"4","key":"6031_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","volume":"24","author":"AL Klauke","year":"2014","unstructured":"Klauke AL, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J, Zimmer A (2014) The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol 24(4):608\u2013620. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.10.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"6031_CR29","volume-title":"Organic Chemistry","author":"D Klein","year":"2015","unstructured":"Klein D (2015) Organic Chemistry, 2nd edn. John Wiley Sons Inc, Hoboken","edition":"2"},{"key":"6031_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","volume":"284","author":"M Kruk-Slomka","year":"2015","unstructured":"Kruk-Slomka M, Michalak A, Biala G (2015) Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system. Behav Brain Res 284:24\u201336","journal-title":"Behav Brain Res"},{"key":"6031_CR31","first-page":"467","volume":"297","author":"WR Lariviere","year":"2001","unstructured":"Lariviere WR, Chesler EJ, Mogil JS (2001) Transgenic studies of pain and analgesia: mutation or background genotype? J Pharmacol Exp Ther 297:467\u2013473","journal-title":"J Pharmacol Exp Ther"},{"key":"6031_CR32","first-page":"1046","volume":"247","author":"PJ Little","year":"1988","unstructured":"Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247:1046\u20131051","journal-title":"J Pharmacol Exp Ther"},{"key":"6031_CR33","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"J McGrath","year":"2010","unstructured":"McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160:1573\u20131576","journal-title":"Br J Pharmacol"},{"key":"6031_CR34","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC"},{"key":"6031_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00011-014-0749-x","volume":"63","author":"MN Nogueira","year":"2014","unstructured":"Nogueira MN, Aquino SG, Rossa Junior C, Spolidorio DM (2014) Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1beta, IL-6 and IL-10 on human macrophages. Inflamm Res 63:769\u2013778","journal-title":"Inflamm Res"},{"key":"6031_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cbi.2016.05.029","volume":"254","author":"MG Oliveira","year":"2016","unstructured":"Oliveira MG, Brito RG, Santos PL, Araujo-Filho HG, Quintans JS, Menezes PP, Serafini MR, Carvalho YM, Silva JC, Almeida JR, Scotti L, Scotti MT, Shanmugam S, Thangaraj P, Araujo AA, Quintans-Junior LJ (2016) alpha-Terpineol, a monoterpene alcohol, complexed with beta-cyclodextrin exerts antihyperalgesic effect in animal model for fibromyalgia aided with docking study. Chem Biol Interact 254:54\u201362","journal-title":"Chem Biol Interact"},{"key":"6031_CR37","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.pain.2012.07.020","volume":"153","author":"Y Otsubo","year":"2012","unstructured":"Otsubo Y, Satoh Y, Kodama M, Araki Y, Satomoto M, Sakamoto E, Pages G, Pouyssegur J, Endo S, Kazama T (2012) Mechanical allodynia but not thermal hyperalgesia is impaired in mice deficient for ERK2 in the central nervous system. Pain 153:2241\u20132252","journal-title":"Pain"},{"issue":"2","key":"6031_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.22038\/ijbms.2016.6546","volume":"19","author":"S Parvardeh","year":"2016","unstructured":"Parvardeh S, Moghimi M, Eslami P, Masoudi A (2016) \u03b1-Terpineol attenuates morphine-induced physical dependence and tolerance in mice: role of nitric oxide. Iranian J Basic Med Sci 19(2):201\u2013208. https:\/\/doi.org\/10.22038\/ijbms.2016.6546","journal-title":"Iranian J Basic Med Sci"},{"key":"6031_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/829414","volume":"2015","author":"FF Passos","year":"2015","unstructured":"Passos FF, Lopes EM, de Araujo JM, de Sousa DP, Veras LM, Leite JR, Almeida FR (2015) Involvement of cholinergic and opioid system in gamma-terpinene-mediated antinociception. Evid Based Complement Alternat Med 2015:829414","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"6031_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.phymed.2013.08.006","volume":"21","author":"LIG Paula-Freire","year":"2014","unstructured":"Paula-Freire LIG, Andersen ML, Gama VS, Molska GR, Carlini ELA (2014) The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine 21(3):356\u2013362. https:\/\/doi.org\/10.1016\/j.phymed.2013.08.006","journal-title":"Phytomedicine"},{"key":"6031_CR41","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1055\/s-0042-107799","volume":"82","author":"TR Ramalho","year":"2016","unstructured":"Ramalho TR, Filgueiras LR, Pacheco de Oliveira MT, Lima AL, Bezerra-Santos CR, Jancar S, Piuvezam MR (2016) Gamma-Terpinene modulation of LPS-stimulated macrophages is dependent on the PGE2\/IL-10 axis. Planta Med 82:1341\u20131345","journal-title":"Planta Med"},{"key":"6031_CR42","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1055\/s-0035-1546169","volume":"81","author":"TR Ramalho","year":"2015","unstructured":"Ramalho TR, Oliveira MT, Lima AL, Bezerra-Santos CR, Piuvezam MR (2015) Gamma-Terpinene modulates acute inflammatory response in mice. Planta Med 81:1248\u20131254","journal-title":"Planta Med"},{"key":"6031_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","volume":"75","author":"JD Richardson","year":"1998","unstructured":"Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75:111\u2013119","journal-title":"Pain"},{"key":"6031_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jphp.12864","volume":"70","author":"S Safaripour","year":"2018","unstructured":"Safaripour S, Nemati Y, Parvardeh S, Ghafghazi S, Fouladzadeh A, Moghimi M (2018) Role of l-arginine\/SNAP\/NO\/cGMP\/KATP channel signalling pathway in antinociceptive effect of alpha-terpineol in mice. J Pharm Pharmacol 70:507\u2013515","journal-title":"J Pharm Pharmacol"},{"key":"6031_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuropharm.2017.07.015","volume":"125","author":"GC Segat","year":"2017","unstructured":"Segat GC, Manjavachi MN, Matias DO, Passos GF, Freitas CS, Costa R, Calixto JB (2017) Antiallodynic effect of beta-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 125:207\u2013219","journal-title":"Neuropharmacology"},{"issue":"3 Suppl","key":"6031_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s1734-1140(10)71119-1","volume":"15","author":"HS Smith","year":"2012","unstructured":"Smith HS (2012) Opioids and neuropathic pain. Pain Physician 15(3 Suppl):93\u2013110. https:\/\/doi.org\/10.1016\/s1734-1140(10)71119-1","journal-title":"Pain Physician"},{"key":"6031_CR47","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s11064-017-2286-9","volume":"42","author":"MD Smith","year":"2017","unstructured":"Smith MD, Woodhead JH, Handy LJ, Pruess TH, Vanegas F, Grussendorf E, Grussendorf J, White K, Bulaj KK, Krumin RK, Hunt M, Wilcox KS (2017) Preclinical comparison of mechanistically different antiseizure, antinociceptive, and\/or antidepressant drugs in a battery of rodent models of nociceptive and neuropathic pain. Neurochem Res 42:1995\u20132010","journal-title":"Neurochem Res"},{"key":"6031_CR48","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.33549\/physiolres.934323","volume":"68","author":"A Spicakova","year":"2019","unstructured":"Spicakova A, Bazgier V, Skalova L, Otyepka M, Anzenbacher P (2019) beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4 - in vitro and in silico studies. Physiol Res 68:S51\u2013S58","journal-title":"Physiol Res"},{"key":"6031_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","volume":"90","author":"AV Stempel","year":"2016","unstructured":"Stempel AV, Stumpf A, Zhang HY, Ozdogan T, Pannasch U, Theis AK, Otte DM, Wojtalla A, Racz I, Ponomarenko A, Xi ZX, Zimmer A, Schmitz D (2016) Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 90:795\u2013809","journal-title":"Neuron"},{"key":"6031_CR50","doi-asserted-by":"publisher","DOI":"10.1201\/9781420036107","volume-title":"Drug synergism and dose-effect data analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug synergism and dose-effect data analysis. Chapman Hall\/CRC Press, Boca Raton"},{"issue":"4","key":"6031_CR51","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155(4):654\u2013662. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013","journal-title":"Pain"},{"key":"6031_CR52","doi-asserted-by":"crossref","unstructured":"Vieira G, Cavalli J, Goncalves ECD, Braga SFP, Ferreira RS, Santos ARS, Cola M, Raposo NRB, Capasso R and Dutra RC (2020) Antidepressant-like effect of terpineol in an inflammatory model of depression: involvement of the cannabinoid system and D2 dopamine receptor. Biomolecules 10.","DOI":"10.3390\/biom10050792"},{"key":"6031_CR53","doi-asserted-by":"crossref","unstructured":"Wilkerson JL, Alberti LB, Kerwin AA, Ledent CA, Thakur GA, Makriyannis A and Milligan ED (2020) Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain. Brain Behav:e01850","DOI":"10.1002\/brb3.1850"},{"key":"6031_CR54","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.pain.2012.02.015","volume":"153","author":"JL Wilkerson","year":"2012","unstructured":"Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Armijo LM, Kuhn MN, Thakur GA, Makriyannis A, Milligan ED (2012) Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain 153:1091\u20131106","journal-title":"Pain"},{"key":"6031_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2016.11.015","volume":"114","author":"JL Wilkerson","year":"2017","unstructured":"Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R, Maldonado RL, Cravatt BF, Lichtman AH (2017) The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology 114:156\u2013167","journal-title":"Neuropharmacology"},{"key":"6031_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.115.229971","volume":"357","author":"JL Wilkerson","year":"2016","unstructured":"Wilkerson JL, Niphakis MJ, Grim TW, Mustafa MA, Abdullah RA, Poklis JL, Dewey WL, Akbarali H, Banks ML, Wise LE, Cravatt BF, Lichtman AH (2016) The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model. J Pharmacol Exp Ther 357:145\u2013156","journal-title":"J Pharmacol Exp Ther"},{"key":"6031_CR57","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A Zimmer","year":"1999","unstructured":"Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A 96:5780\u20135785","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06031-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-06031-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-06031-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T01:10:29Z","timestamp":1652663429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-06031-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6031"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-06031-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}